Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

President Donald Trump announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 ...

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in ...

NBC News' Tom Llamas talks to CEO of Eli Lilly David Ricks about the company's new deal with the Trump administration to cut ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Trump secures a major deal with Eli Lilly and Novo Nordisk to cut obesity drug costs as Medicare expands coverage for ...

A new weight-loss drug from Eli Lilly & Co. helped patients shed as much weight as popular shots like Zepbound, giving the company another edge in the fast-growing obesity market.

The Trump administration’s new TrumpRx deal with Eli Lilly and Novo Nordisk will slash GLP-1 drug prices, including Ozempic, ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Trump administration strikes deal with Novo Nordisk and Eli Lilly to slash weight-loss drug costs. Wegovy starting doses drop ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...

Even after Trump’s new deal, obesity drugs are still too expensive.